Enzyme responsive nanocapsules for protein delivery

US9993440B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9993440-B2
Application numberUS-201214342524-A
CountryUS
Kind codeB2
Filing dateSep 4, 2012
Priority dateSep 2, 2011
Publication dateJun 12, 2018
Grant dateJun 12, 2018

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The invention provides methods of making and using compositions comprising a polymer shell designed to deliver polypeptides to selected environments. In embodiments of the invention, different environmental conditions are harnessed to allow the selective degradation of the polymer shell and the consequential release of one or polypeptides encapsulated therein. In illustrative embodiments, polymer components of the shell are interconnected by peptide-containing crosslinker moieties, linkages which maintain the integrity of the polymer shell under certain environmental conditions, but can also be cleaved when combined with a selected protease.

First claim

Opening claim text (preview).

The invention claimed is: 1. A composition of matter comprising: at least one polypeptide; a polymeric network, wherein: polymers in the polymeric network are coupled together by a first crosslinking agent and a second crosslinking agent so as to form a shell that encapsulates the polypeptide; the first crosslinking agent comprises a peptide having an amino acid sequence that is cleaved by a protease, wherein amino acid sequence that is cleaved by the protease comprises KNRVK (SEQ ID NO: 1), GGIPVSLRSGGK (SEQ ID NO: 2) or GGVPLSLYSGGK (SEQ ID NO: 3); and the second crosslinking agent does not comprise a peptide having an amino acid sequence that is cleaved by a protease; wherein the polymers, the first crosslinking agent and the second crosslinking agent are disposed within the polymeric network in an orientation so that proteolytic cleavage of the first crosslinking agent releases the polypeptide from the shell into an external environment. 2. The composition of claim 1 , wherein relative molar amounts of the first crosslinking agent and the second crosslinking agent in the shell are at least 1:5, 1:4, 1:3, 1:2, 1:1, 2:1, 3:1, 4:1 or 5:1. 3. The composition of claim 1 , wherein shell that encapsulates the polypeptide has a diameter between 15 and 35 nanometers. 4. The composition of claim 1 , wherein the polypeptide comprises a protein that stimulates cellular growth. 5. The composition of claim 1 , wherein the composition further comprises a hydrogel in which the shell is disposed. 6. The composition of claim 5 , wherein the shell is covalently coupled to the hydrogel by a hydrogel crosslinking agent. 7. The composition of claim 6 , wherein the hydrogel crosslinking agent comprises a peptide having an amino acid sequence that is cleaved by a protease. 8. The composition of claim 1 , wherein the first crosslinking agent comprises a peptide having D-amino acids. 9. The composition of claim 1 , wherein the concentration of the first crosslinking agent in the composition relative to the concentration of the second crosslinking agent in the composition is controlled so as to modulate the rate at which the polypeptide is released from the shell into an external in vivo environment. 10. The composition of claim 9 , wherein the concentration of the first crosslinking agent is greater than the concentration of the second crosslinking agent in order to modulate the rate at which the polypeptide is released from the shell into an external in vivo environment. 11. The composition of claim 9 , wherein the concentration of the first crosslinking agent is less than the concentration of the second crosslinking agent in order to modulate the rate at which the polypeptide is released from the shell into an external in vivo environment. 12. A composition of matter comprising: at least two polypeptides; a polymeric network, wherein: polymers in the polymeric network are coupled together by a first crosslinking agent and a second crosslinking agent so as to form a shell that encapsulates the at least two polypeptides; the first crosslinking agent comprises a peptide having an amino acid sequence that is cleaved by a protease, wherein amino acid sequence that is cleaved by the protease comprises KNRVK (SEQ ID NO: 1), GGIPVSLRSGGK (SEQ ID NO: 2) or GGVPLSLYSGGK (SEQ ID NO: 3); and the second crosslinking agent does not comprise a peptide having an amino acid sequence that is cleaved by the protease; wherein the polymers, the first crosslinking agent and the second crosslinking agent are disposed within the polymeric network in an orientation so that proteolytic cleavage of the first crosslinking agent releases the at least two polypeptides from the shell into an external environment.

Assignees

Inventors

Classifications

  • Processes · CPC title

  • Peptidic linkers, binders or spacers, e.g. peptidic enzyme-labile linkers · CPC title

  • lyophilised {, i.e. freeze-dried, solutions or dispersions (lyophilised products with subsequent particle size reduction A61K9/14; granules or pellets made by lyphilisation A61K9/1682; solid oral dosage forms made by lyophilisation A61K9/2095; lyophilisation additives A61K47/00)} · CPC title

  • A61K9/5169Primary

    Proteins, e.g. albumin, gelatin · CPC title

  • obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9993440B2 cover?
The invention provides methods of making and using compositions comprising a polymer shell designed to deliver polypeptides to selected environments. In embodiments of the invention, different environmental conditions are harnessed to allow the selective degradation of the polymer shell and the consequential release of one or polypeptides encapsulated therein. In illustrative embodiments, polym…
Who is the assignee on this patent?
Lu Yunfeng, Segura Tatiana, Zhu Suwei, and 2 more
What technology area does this patent fall under?
Primary CPC classification A61K9/5169. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Jun 12 2018 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).